Instalab
logoInstalab

Syphilis Screen with Titer

Blood Test
See not just whether you've been exposed to syphilis, but whether the infection is active and responding to treatment.
4.9 (4,537 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Syphilis Screen with Titer test?

This test is most useful if any of these apply to you.

Dating or With New Partners
You are sexually active with new or multiple partners and want to catch a common, often silent infection early.
Living With HIV or On PrEP
You are on PrEP (HIV-prevention medicine) or living with HIV, which raises syphilis risk, so frequent screening helps.
Pregnant or Planning To Be
You want to protect a future pregnancy, since untreated syphilis can pass to a baby and screening prevents it.
Tracking After Treatment
You were treated for syphilis and want to confirm your antibody level has dropped fourfold, the sign of a cure.

About Syphilis Screen with Titer

Syphilis is one of the fastest-rising infections in the United States, and it is fully curable when caught early. The catch is that it often causes no symptoms you would notice, which is exactly why a proactive blood test matters.

This panel is the standard first look. In a single blood draw it does two things: it detects whether your immune system is reacting to the infection, and it measures how strong that reaction is.

What This Panel Reveals

Both tests here use the same method, called RPR (rapid plasma reagin). It does not detect the syphilis bacterium directly. Instead it picks up antibodies (called reagin) that your body makes against fatty molecules released when syphilis damages tissue. Those antibodies tend to rise when infection is active and fall after successful treatment, which is what makes them useful.

The screen answers a simple yes or no: are those antibodies present? The titer answers the follow-up question the screen cannot: how much? Antibody amount is reported as a dilution, such as 1 to 8 or 1 to 64, meaning how far your blood can be diluted and still test positive. A higher number means a stronger response.

Read together, the two give you presence and intensity in one picture. A reactive screen tells you something is there. The titer tells you whether it looks recent and active, and gives you the single number every future result will be compared against.

How to Read Your Results Together

The value of pairing a yes-or-no screen with a number is that a single reactive result cannot tell you whether antibody levels are low, high, rising, or falling. The titer supplies that missing layer. Here are the common patterns.

Your ResultWhat It Suggests
Nonreactive screenSyphilis is unlikely, though a very recent infection can be missed because antibodies can take roughly 3 to 6 weeks to appear.
Reactive screen, higher titer (1 to 8 or above)More consistent with recent or active infection, though titers vary by stage. Needs a confirmatory treponemal test and prompt clinical follow-up.
Reactive screen, low titer (1 to 4 or below)Can mean early infection, old treated infection, late-stage infection, or a false positive. Context and a confirmatory test decide.
Titer rising fourfold over time (for example 1 to 8 up to 1 to 32)Points to reinfection or treatment failure and warrants re-evaluation.

The fourfold rule appears throughout this panel because a single dilution of movement can just be normal test noise. Only a fourfold change, meaning two dilution steps, is treated as clinically meaningful. Across cohort studies, a fourfold or greater drop from your pre-treatment baseline is the accepted sign of a successful cure.

What to Do with Your Results

A reactive RPR is never the end of the story on its own. Because this test is not specific to syphilis, any reactive result should be confirmed with a treponemal test, a second blood test that detects antibodies aimed at the syphilis bacterium itself. If both point to infection, a clinician can stage it and treat it, usually with penicillin.

Once treated, the titer becomes a tracking tool. Guidelines have you retest at 6 and 12 months for early syphilis, and 12 to 24 months for later stages, watching for that fourfold decline. In pregnancy, one small study found treated antibody levels fell with a median half-life of about 39 days, so serial titers can give reassurance that therapy is working, though many women will not reach a fourfold drop before delivery. If you are at ongoing risk, the U.S. Preventive Services Task Force (USPSTF) notes that the best screening frequency is not well established, but early evidence suggests testing every 3 months may catch more early infections in higher-risk men than annual testing, so more frequent retesting is reasonable if you are actively managing your health.

When Results Can Be Misleading

A few things affect this whole panel at once. Very high antibody levels can paradoxically produce a false nonreactive result, an effect called the prozone phenomenon, which one large study found across titers from 1 to 8 up to 1 to 512; a good lab reruns diluted samples when suspicion is high. False positives also happen because reagin antibodies are not unique to syphilis. Pregnancy, autoimmune disease, other infections, and HIV, the virus that causes AIDS, can all trigger them; in one HIV cohort 13.5% of patients had biologic false-positive results, most at low titers.

Titers themselves carry some noise. Different laboratories can report results that differ by up to threefold, so tracking your trend on the same platform gives the cleanest read.

Frequently Asked Questions

References

10 studies
  1. S. Tuddenham, Samantha S. Katz, K. GhanemClinical Infectious Diseases2020
  2. K. Pandey, C. Fairley, Marcus Y. Chen, D. Williamson, C. Bradshaw, J. Ong, Ei T. Aung, E. ChowClinical Infectious Diseases2022
  3. A. Seña, M. Wolff, F. Behets, D. Martin, P. Leone, C. Langley, L. Mcneil, E. HookSexually Transmitted Diseases2017
  4. Li-Li Liu, Li-rong Lin, Man-li Tong, Tian-ci YangClinical Infectious Diseases2014